Analyst Ratings for BioCryst Pharma (BCRX) [Buys]
BCRX Rating Summary
BCRX Price Target Summary
- Highest: $14.00 (JMP Securities)
- Lowest: $6.00 (Barclays)
- Average: $10.17
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$10.17 (+129.5%)
* Over Last 12-Mos
Rating Score: 8.1 / 10
Percentile Rank: 85%
Avg. $ Target:
$10.17 (+129.5%)
* Over Last 12-Mos
Rating Score: 8.1 / 10
Percentile Rank: 85%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 11/20/2023 | JPMorgan | Jessica Fye | New Coverage | Overweight (N/A) |
10.00 (N/A) |
5.14 (4.43) |
-13.81% | Details |
| 9/18/2023 | RBC Capital | Brian Abraham | Upgrade | Outperform (Sector Perform) |
10.00 (9.00) |
6.85 (4.43) |
-35.33% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
